tradingkey.logo
tradingkey.logo
Suchen

Oncology Institute Inc

TOI
Zur Watchlist hinzufügen
5.280USD
-0.230-4.17%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
522.00MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Oncology Institute Inc Unternehmen

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Oncology Institute Inc Informationen

BörsenkürzelTOI
Name des UnternehmensOncology Institute Inc
IPO-datumMar 13, 2020
CEOVirnich (Daniel)
Anzahl der mitarbeiter825
WertpapierartOrdinary Share
GeschäftsjahresendeMar 13
Addresse18000 Studebaker Rd
StadtCERRITOS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl90703
Telefon15627353226
Websitehttps://theoncologyinstitute.com/
BörsenkürzelTOI
IPO-datumMar 13, 2020
CEOVirnich (Daniel)

Führungskräfte von Oncology Institute Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
-53.54%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
692.92K
-3.33%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
153.78K
+36.25%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
116.92K
-147.27%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
49.68K
-3.23%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
43.80K
-53.54%
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Oncology Institute Inc?

Die fünf größten Anteilseigner von Oncology Institute Inc sind: Dr. Daniel Virnich, M.D.

Wie viele Institutionen halten Anteile an Oncology Institute Inc (TOI)?

Mit Stand vom 2026Q1 halten 204 Institutionen Anteile an Oncology Institute Inc, mit einem Gesamtmarktwert von etwa 47.47M, was 47.57% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -10136464.00 gestiegen.

Was ist die größte Einnahmequelle von Oncology Institute Inc?

Am 2026Q1 erzielte das Geschäft mit Dispensary revenue für Oncology Institute Inc den höchsten Umsatz in Höhe von 269.18M, was 53.54% des Gesamtumsatzes entspricht.